Trials / Completed
CompletedNCT06265077
Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients
Efficacy and Safety of Loratadine and Famotidine Combination on Preventing Filgrastim-Induced Bone Pain in Breast Cancer Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Noha Mansour · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
No randomized controlled trial evaluated the safety and efficacy of double blockade on G-CSF induced bone pain. Therefore, this study aims to evaluate the efficacy and safety of double blockade on the incidence and severity of G-CSF induced bone pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo |
| DRUG | famotidine and loratadine | famotidine 20 mg once daily and loratadine 10 mg once daily |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2024-10-17
- Completion
- 2024-10-17
- First posted
- 2024-02-20
- Last updated
- 2024-12-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06265077. Inclusion in this directory is not an endorsement.